Females more likely to think their vision is bad after surgery

Article

Female cataract surgery patients are more likely to assess their postoperative visual function as worse than male patients.

Female cataract surgery patients are more likely to assess their postoperative visual function as worse than male patients, according to a report published online ahead of print by Acta Ophthalmologica.

Britta Lundqvist and Eva Mönestam from Norrlands University Hospital, Umeå, Sweden conducted a prospective, longitudinal, population-based cohort study to analyze gender-related differences in subjective and objective visual function five-years after cataract surgery.

A total of 810 patients who had undergone cataract surgery between 1997 and 1998, had their visual acuity (VA) examined and were asked to complete questionnaires (VF-14) before surgery, immediately following surgery and five-years later. Five-hundred and thirty patients (177 men, 353 women) answered the questionnaire and 467 (156 men, 311 women) also underwent the VA examination.

Prior to and following surgery, women had a significantly lower age- and VA-adjusted VF-14 score (p=0.000 and p=0.036, respectively). This difference was not significant five years after surgery (p=0.16). Five years postoperatively, a significantly larger proportion of women had a decline of more than 0.1 logarithm of the minimum angle of resolution of the better-seeing eye (p=0.013) but there were no significant gender-related differences in the operated eye.

It was the conclusion of this study that women are more likely to assess their postoperative visual function as worse than their male counterparts.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.